Header Logo

Connection

Peter Konrad to Cost-Benefit Analysis

Back to Details
This is a "connection" page, showing publications Peter Konrad has written about Cost-Benefit Analysis.
Peter Konrad
Connection Strength
0.061
Cost-Benefit Analysis
  1. Cost-effectiveness of vagus nerve-mediated neuroimmune modulation for the treatment of moderate-to-severe rheumatoid arthritis. J Med Econ. 2026 Dec; 29(1):1462-1473.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.